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Marked regression of tumor occupying almost the entire breast 
following chemotherapys
Figure 1 Figure 2 
Image from a 26-year old, breast-feeding woman, G6, 
P6, delivered seven months previously and hospitalized 
with an advanced breast tumor affecting the entire right 
breast. The tumor was ulcerated, infected, infiltrating the 
chest wall and ipsilateral axillary lymph nodes fixed to one 
another (Figure 1). Chest x-ray, chest and abdomen CT, 
and bone scintigraphy detected no signs of metastases. 
Histology revealed a poorly differentiated invasive ductal 
carcinoma. Therefore, T4cN2aMO, stage IIIc. The patient 
ceased breast-feeding and received primary chemothera-
py with doxorubicin and cyclophosphamide (four cycles) 
followed by four cycles of paclitaxel, culminating in ma-
rked regression of the tumor and mammary gland (Figure 
2). The patient received additional radiotherapy; however, 
there was a recurrence of the lesion locally and in the lungs 
nine months later. 
Breast cancer that occurs during pregnancy or wi-
thin one year after an obstetric delivery is considered 
pregnancy-associated breast cancer. The women with this 
association are at a statistically significant higher risk of 
presenting with a more advanced disease, worse prognosis 
and higher risk of death1. Anthracyclines and taxanes are 
the most active widely used chemotherapeutic agents in 
the treatment of advanced breast cancer2, as in the present 
case. To our knowledge, this is the first report of marked 
regression of tumor and mammary gland following che-
motherapy for advanced breast cancer in a young breas-
tfeeding woman. 
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